Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
319 Leser
Artikel bewerten:
(1)

Cognition and Memory Enhancement Market worth $38.9 billion by 2026 - Exclusive Report by MarketsandMarkets

CHICAGO, May 23, 2022 /PRNewswire/ -- According to the new market research report "Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) - Global Forecast to 2026", published by MarketsandMarkets, the global Memory Enhancement Market is projected to reach USD 38.9 billion by 2026 from USD 23.4 billion in 2021, at a CAGR of 10.7% during the forecast period.

MarketsandMarkets_Logo

Browse in-depth TOC on "Cognition and Memory Enhancement Market"
7 - Tables
3 - Figures
25 - Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=23532463

The Growing adoption of nutraceuticals for cognitive health is among the primary factors that drive the market growth. To achieve a better quality of life and cognitive health, consumers of all ages have started including more vegetables, fruits, dietary supplements, probiotics, prebiotics, phytotherapeutic substances, and other plant foods in their diets. Consequently, there has been an increase in the demand for nutraceutical ingredients over the past few years, as they are being used by consumers for various health benefits

The cognition & memory-enhancing drugs segment accounted for the largest share of the cognition enhancement market in 2020.

On the basis of product & service, the memory enhancement market is segmented into cognition & memory-enhancing drugs, brain-boosting nutraceuticals, and cognitive assessment & training solutions. In 2020, the cognition & memory-enhancing drugs segment accounted for the largest segment of the cognition and memory enhancement market. The large share of this segment can primarily be attributed to the increasing R&D by leading pharmaceutical companies in dementia-related diseases such as Alzheimer's.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=23532463

The Asia Pacific region is the fastest-growing region of the cognition enhancement market in 2020.

The memory enhancement market in the Asia Pacific region is projected to register the highest growth during the forecast period. Growing prevalence of neurological disorders in this region is a major factors driving the growth of the Asia Pacific market.

Some of the leading players operating in the cognition enhancement market include Eisai Co., Ltd. (Japan), Johnson & Johnson Services, Inc. (US), Biogen Inc. (US), Eli Lilly and Company (US), Nordic Naturals (US), Natrol, LLC (US), Cambridge Cognition Ltd. (UK), and Cogstate Ltd. (US).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=23532463

Browse Adjacent Markets: Pharmaceuticals Market Research Reports & Consulting

Browse Related Reports:

Healthcare Virtual Assistants Market by Product (Chatbots, Smart Speakers), User Interface (Automatic Speech Recognition, Text Based, Text-to-Speech Based), End User (Healthcare Providers, Patients, Healthcare Payers) - Global Forecast to 2024
https://www.marketsandmarkets.com/Market-Reports/healthcare-virtual-assistant-market-214922625.html

Medical Device Connectivity Market by Product & Services (Integration Solutions, Telemetry, Connectivity Hubs), Technology (Wired, Hybrid), Application (Vital signs Monitors, Ventilators), End User (Hospitals) - Global Forecast to 2026
https://www.marketsandmarkets.com/Market-Reports/medical-device-connectivity-market-83792455.html

About MarketsandMarkets

MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cognition-memory-enhancement-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/cognition-memory-enhancement.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

© 2022 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.